Dayhoff Health provides stop-loss organizations with population-level insights into the gut microbiome to identify early biological risk signals, inform preventative strategies, and reduce exposure to high-cost claims across covered lives.
Dayhoff Health does not diagnose or treat disease.
Stop-loss carriers typically react after risk has already surfaced. Claims data reflects utilization, not early biological change, leaving limited visibility before high-cost events occur.
Some of the earliest indicators of long-term health risk emerge biologically well before diagnosis or escalation. The gut microbiome is one of those signals.
Dayhoff Health delivers population-level microbiome insight designed to help stop-loss stakeholders identify emerging risk patterns before they appear in claims data. Using advanced laboratory and bioinformatics methods, we translate complex biological signals into aggregated, de-identified insights that support proactive risk strategy.
Dayhoff does not diagnose or treat disease. Our role is to provide early population insight that complements existing actuarial and risk frameworks without assuming clinical responsibility.
Diagnostic or Predictive Underwriting Tool 
Replacement for Actuarial or Claims Analysis 
Treatment or Care Delivery Platform 
Performance Surveillance System These boundaries ensure the responsible use of biological insights in stop-loss and insurance environments.
Dayhoff Health gives stop-loss partners earlier visibility into what's developing across their covered population, turning emerging health signals into insight before they become costly events.
100,000 → 60,000 living with a chronic condition
100,000 lives → 1,000–2,000 high-cost claimants
Source: CDC, National Alliance of Healthcare Purchaser Coalitions
Dayhoff Health identifies early biological patterns related to inflammation, metabolism, immune function, and recovery across populations.
These insights help stop-loss organizations understand risk earlier, before it escalates into high-cost claims, without crossing into diagnosis or treatment.
By surfacing emerging risk earlier, Dayhoff helps stop-loss stakeholders:
Risk mitigation starts with visibility. Dayhoff provides that visibility responsibly.
Dayhoff supports population health initiatives across:
Programs are designed to scale across diverse populations while maintaining strict privacy, governance, and data integrity standards.
Stop-loss providers use Dayhoff to gain earlier visibility into biological risk trends across covered populations, without relying solely on lagging indicators like claims.
Dayhoff enhances risk intelligence without disrupting existing underwriting or actuarial processes.
Participants receive:
This approach promotes engagement and prevention while preserving autonomy and privacy.
Dayhoff is built for privacy, governance, and trust.
This approach protects participants while giving stop-loss organizations confidence in the responsible handling of data.
Whether you are evaluating new population health initiatives or strengthening existing risk mitigation programs, Dayhoff provides early insight with clarity, restraint, and rigor.